共 50 条
NfL makes regulatory debut as neurodegenerative disease biomarker
被引:22
|作者:
Mullard, Asher
机构:
关键词:
D O I:
10.1038/d41573-023-00083-z
中图分类号:
Q81 [生物工程学(生物技术)];
Q93 [微生物学];
学科分类号:
071005 ;
0836 ;
090102 ;
100705 ;
摘要:
The FDA approved tofersen for amyotrophic lateral sclerosis based on the drug’s ability to lower blood levels of neurofilament light (NfL) — establishing a proof of potential for this neuroscience biomarker that could have implications for other diseases of the brain.
引用
收藏
页码:431 / 434
页数:4
相关论文